| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.72▲ | 3.68▲ | 3.67▲ | 3.70▲ | 3.79▼ |
| MA10 | 3.70▲ | 3.66▲ | 3.66▲ | 3.71▲ | 3.78▼ |
| MA20 | 3.68▲ | 3.66▲ | 3.67▲ | 3.86▼ | 2.83▲ |
| MA50 | 3.66▲ | 3.70▲ | 3.71▲ | 3.74▲ | 2.00▲ |
| MA100 | 3.66▲ | 3.71▲ | 3.87▼ | 2.78▲ | 2.87▲ |
| MA200 | 3.66▲ | 3.90▼ | 3.80▼ | 2.00▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.009▲ | 0.009▲ | -0.045▼ | 0.087▲ |
| RSI | 67.028▲ | 56.002▲ | 52.928▲ | 50.191▲ | 61.577▲ |
| STOCH | 73.611 | 45.007 | 50.556 | 34.468 | 61.597 |
| WILL %R | 0.000▲ | -25.000▲ | -30.303 | -68.027 | -33.571 |
| CCI | 146.217▲ | 106.215▲ | 118.095▲ | -32.691 | 37.242 |
|
Friday, November 28, 2025 10:26 PM
With strong three-month performance and significant upside potential, Zura Bio Limited (NASDAQ:ZURA) secures a spot on our list of the 12 hot penny stocks to invest in right now. On November 13, 2025, ...
|
|
Thursday, November 13, 2025 03:30 AM
Continued advancement of two Phase 2 clinical trials evaluating tibulizumab in hidradenitis suppurativa (HS) (TibuSHIELD) and systemic sclerosis (SSc) (TibuSURE), with topline data expected in the ...
|
|
Wednesday, November 12, 2025 10:30 PM
Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/12/25 | 3.74 | 3.74 | 3.74 | 3.74 | 7,467 |
| 03/12/25 | 3.51 | 3.816 | 3.51 | 3.68 | 444,400 |
| 02/12/25 | 3.73 | 3.84 | 3.505 | 3.51 | 308,900 |
| 01/12/25 | 3.77 | 3.78 | 3.515 | 3.72 | 355,000 |
| 28/11/25 | 3.84 | 3.95 | 3.72 | 3.84 | 225,215 |
| 26/11/25 | 3.80 | 3.88 | 3.68 | 3.80 | 359,200 |
| 25/11/25 | 3.78 | 3.871 | 3.66 | 3.75 | 291,500 |
| 24/11/25 | 3.65 | 3.77 | 3.623 | 3.74 | 253,000 |
| 21/11/25 | 3.70 | 3.7853 | 3.57 | 3.63 | 414,480 |
| 20/11/25 | 3.97 | 3.97 | 3.6385 | 3.67 | 301,664 |
|
|
||||
|
|
||||
|
|